JMOM JPMorgan U.S. Momentum Factor ETF
Profitability Metrics
Valuation Metrics
Growth & Cash Flow
Price Change
Top 10 Holdings
| Stock Ticker | Weight |
|---|---|
| AAPL | 2.22% |
| NVDA | 2.04% |
| AVGO | 2.01% |
| AMD | 2.00% |
| GOOGL | 1.99% |
| JNJ | 1.88% |
| META | 1.82% |
| MU | 1.79% |
| MSFT | 1.69% |
| WMT | 1.30% |
ETF Analysis
Fund Overview
JPMorgan U.S. Momentum Factor ETF (JMOM) currently reports 288 stock positions (subject to change), placing it in the broadly constructed range by holdings breadth. The top line-up is AAPL (2.22%), NVDA (2.04%), AVGO (2.01%), with AAPL as the largest single weight at 2.22%. Together, the top three holdings account for 6.27%, which suggests the fund is not overly reliant on its largest positions to generate returns. The fund's architecture positions it to benefit from strength in its top holdings while the broader basket provides a degree of insulation against single-name shocks.
Profitability & Capital Efficiency
Looking at how effectively the underlying holdings deploy capital, ROIC is 26.28%, WACC is 9.76%, and the economic spread is 16.52%. On balance, returns on invested capital exceed the cost of funding by a comfortable margin, which over time compounds favorably for long-term holders. Supporting metrics show ROE at 32.00% and ROA at 9.51%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio with credible compounding capacity if current operating execution persists.
Valuation
On valuation, the portfolio registers trailing P/E of 27.15, forward P/E of 20.64, PEG of 1.84. The spread between the two P/E figures is moderate, suggesting earnings are expected to improve gradually rather than accelerate sharply. The PEG reading here implies the market is pricing growth at roughly fair value — a setup where the investment case depends more on execution than on multiple expansion. A current ratio reading of 2.35 points to holdings that are managing short-term obligations without apparent stress. Taken together, the multiple and liquidity picture suggests a portfolio that is priced for a constructive outcome — but where execution against earnings estimates will be the key determinant of whether that price is justified.
Margins & Cash Generation
Across the three margin layers, gross margin sits at 52.98%, operating margin at -20.47%, and free cash flow margin at 20.38%. Gross margins sit in a healthy range, consistent with businesses that manage input costs effectively. The portfolio's operating margins are minimal, reflecting a holding set where overhead costs are not yet well absorbed by revenues. At this level, free cash flow margins suggest businesses that are building financial strength alongside revenue growth. Read together, these margin levels suggest a portfolio where earnings durability is present in parts but not consistent across the full holding set.
Growth & Forward Outlook
On a forward-looking basis, TTM revenue growth of 33.87% a signal of strong operational momentum across the holding set, while the estimated 12-month price change of 20.14%, where the target distribution indicates incremental upside rather than outsized repricing. Revenue growth and price targets are correlated but not the same — strong operations do not always translate to strong price appreciation, and vice versa. The forward return case rests on whether the businesses can sustain their operating trajectory long enough for analyst price targets to be reached or exceeded. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.
Conclusion
Strong BuyThe full scorecard here is hard to argue with: capital efficiency is strong, margins are healthy, and growth is being priced constructively.
This assessment reflects quantitative metrics only and does not constitute financial advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.